Bought some more at $.47 this AM. Given that Ori converted at $1.08 and other shareholders are in at well over this is a bargain, imo.   I think the fact that the major shareholder is Chinese Based is a  drag on share price and makes it complicated to do a deal with a name Big pharma based in N.A. or Europe, not to mention the myriad of other issues mentioned here several times before. If they get something going on Covid great but I am not counting on it. I think they can do something with BTD and Eversana eventually. Just sitting tight now for what could be a long haul. They could sell for at least $200 million or so to someone else if it gets that desperate, hopefully.